Anthony B. Evnin, Director at MEMORY PHARMACEUTICALS CORP (MEMY), bought 963,855 shares at $1.11 ($1.1M) on 2006-10-16, disclosed to the SEC on 2006-10-18.
Open-market purchase of $1.1M MEMY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.11 | 87,623 | $97K | 9.1% |
| 2 | $1.11 | 359,255 | $399K | 37.3% |
| 3 | $1.11 | 516,977 | $574K | 53.6% |
| Total | $1.11 avg | 963,855 | $1.1M | 100% |
| Filing → |
| CNST | BUY | 2019-10-04 | $48.0M | — | Filing → |
| AVEO | BUY | 2018-11-26 | $223 | — | Filing → |
| AVEO | SELL | 2018-11-16 | $4.3M | — | Filing → |